ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.049100146992119 0.022673404
NSC 134723 K 31 0.049100146992119 0.62941724
NSC 13484 Null 0.049100146992119 -0.16566349
NSC 135073 WITHACNISTIN 0.049100146992119 -0.19155199
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.049100146992119 -0.092841601
NSC 176323 Camptothecin Derivative 0.049100146992119 0.5479678
NSC 21683 Null 0.049100146992119 0.085832194
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.049100146992119 0.025523703
NSC 295272 Null 0.049100146992119 0.20231242
NSC 295499 Camptothecin Derivative 0.049100146992119 0.40959309
Total:119  Current:108    [First] [Prev] [Next] [Last]